Target intelligence / Profile preview

Cytochrome c (CYCS)

Target
CYCS
Molecular classification
Enzyme (electron carrier protein), Heme protein, Mitochondrial protein, Class I c-type cytochrome family
01

Overview

Cytochrome c is a small (~12 kDa), highly conserved heme protein located primarily within the mitochondrial intermembrane space[1]. It functions as an electron carrier between Complex III (cytochrome bc1 complex) and Complex IV (cytochrome oxidase) of the respiratory electron transport chain—an essential process for ATP synthesis during oxidative phosphorylation[1][4]. Structurally, it consists of about 104 amino acids with a covalently attached heme group coordinated by histidine and methionine residues[1]. Beyond energy metabolism, it plays a pivotal role in intrinsic apoptosis; upon cellular stress or damage leading to mitochondrial outer membrane permeabilization, cytochrome c is released into the cytosol where it helps form the apoptosome complex with Apaf‑1—triggering caspase activation and programmed cell death[1]. Its involvement extends to redox homeostasis and peroxidase activity under certain conditions. Dysregulation of these processes links cytochrome c to various diseases including cancer, neurodegeneration, cardiovascular disorders, and other pathologies associated with impaired apoptosis or oxidative stress responses[7].

Other names
cytochrome-ccyt-cCYCcytochrome c oxidase (note: "cytochrome c oxidase" is a distinct enzyme complex but sometimes confused in literature)mitochondrial cytochrome c
02

Mechanism of action

Drugs or agents that affect cytochrome c typically act by modulating its release from mitochondria to the cytosol during apoptosis. This can be achieved by influencing mitochondrial membrane permeability or targeting proteins involved in apoptotic regulation.

03

Biological functions

Electron transport chain (mitochondrial respiration)Apoptotic signaling (intrinsic apoptosis pathway)Redox homeostasis and oxidative stress responsePeroxidase activity
04

Disease associations

Cancer (apoptosis dysregulation)Neurodegenerative disease (e.g., Parkinson’s, Alzheimer’s; mitochondrial dysfunction and cell death)Cardiovascular disease (ischemia-reperfusion injury via apoptosis)Other diseases involving oxidative stress or mitochondrial dysfunction
05

Safety considerations

Targeting cytochrome c directly poses significant safety concerns due to its essential role in cellular energy production; inhibition could cause widespread toxicity. Modulating its apoptotic function risks unintended cell death or survival of damaged cells.
06

Interacting drugs

There are no widely approved drugs that directly target cytochrome c for therapeutic purposes. However, some experimental compounds and research tools modulate its release or function indirectly through upstream pathways affecting mitochondria.
07

Biomarkers

Cytochrome c levels in blood or tissues can serve as biomarkers for cell death/apoptosis and tissue injury—especially in contexts like myocardial infarction, stroke, sepsis, and neurodegeneration.

Beyond the preview

Go deeper on Cytochrome c (CYCS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome c (CYCS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call